about
MEF2C exon α: role in gene activation and differentiationBlockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism.The contribution of the citrate pathway to oxidative stress in Down syndrome.The mitochondrial aspartate/glutamate carrier isoform 1 gene expression is regulated by CREB in neuronal cells.Glutamine synthetase desensitizes differentiated adipocytes to proinflammatory stimuli by raising intracellular glutamine levels.Mitochondrial carriers in inflammation induced by bacterial endotoxin and cytokines.ATP-citrate lyase is essential for macrophage inflammatory response.A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency.Glutamine Synthetase: Localization Dictates Outcome.Metabolism and TAM functions-it takes two to tango.Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor.Acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate/malate exchange activity to sustain NADPH production during macrophage activationMonoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injuryFOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cellsThe Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication
P50
Q24322737-6E45AE1C-538A-4C7E-BF11-46352E9A62E1Q37695150-13E369D1-EF91-492B-8B30-450D4B297ADCQ38622042-34EA15C2-87E0-4CDC-BF76-977777A13A3CQ38719674-7E784406-D697-48B4-93CA-B889B7C20874Q38733639-50E0AF8B-ADF1-4AEF-A61A-7C81B4F36226Q38918962-09FD3047-076C-40B7-BD91-13D6088786BBQ38934612-EAF81521-38C5-4834-9F79-9E8E7D4880B6Q38977968-1BDD2EA3-084A-4C7D-8B2A-72B4A6E992EFQ39094030-2CE5BFB6-A6A9-40A7-8007-E64EFD9F39D5Q41956191-637A54A9-9A81-4D13-A2AD-7064190F7F12Q47323767-015B2B03-C7BF-498F-BA2B-0C19121E331BQ49798196-983C3FEF-8987-49A0-B465-E2F0D6535F87Q50063084-3B8CD176-523B-419F-B681-3953AE64A998Q53804185-8306FBFB-AF78-4389-81ED-63D29DA25A7DQ56866599-35FB9AF3-4EEA-416E-949A-0DD110269A1FQ89314035-B208B51F-3A66-4EF6-9DF4-1F7FCF6E524CQ90751080-CD15272C-2269-4F02-BCAE-567E4E9448D5Q92081909-1558373E-85D8-42CD-BD02-5AAF06BFE1DE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessio Menga
@ast
Alessio Menga
@en
Alessio Menga
@es
Alessio Menga
@nl
type
label
Alessio Menga
@ast
Alessio Menga
@en
Alessio Menga
@es
Alessio Menga
@nl
prefLabel
Alessio Menga
@ast
Alessio Menga
@en
Alessio Menga
@es
Alessio Menga
@nl
P106
P1153
55348856000
P31
P496
0000-0002-2827-5298